https://alzheimereurope.newsweaver.com/Newsletter/ en-us 02 Jul 2021 02:07:00 CEST 02 Jul 2021 02:07:00 CEST https://alzheimereurope.newsweaver.com/Newsletter/rss.xml Newsweaver info@alzheimer-europe.org () support@newsweaver.ie (Newsweaver) 60 true https://alzheimereurope.newsweaver.com/Newsletter/1nftsivxjjz?lang=en?rss=true Alzheimer Europe’s June 2021 newsletter [ https://alzheimereurope.newsweaver.com/Newsletter/1d5hr7hr5qp/external ] brings you the latest news on developments in the dementia field, across Europe and beyond. Summaries of a few of our top stories appear below. Our monthly newsletter reaches around 11,000 people and we are always happy to receive feedback, or suggestions regarding news items to share in future issues. [ https://alzheimereurope.newsweaver.com/Newsletter/1d5hr7hr5qp/external ] 02 Jul 2021 12:00:00 CEST ccbd98fda20681db5ab5c76177f6316f Feature Article <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/2b/92a8976269fb1f449eddd2.jpg" style="margin: 5px;" width="150" height="100" hspace="5" vspace="5" alt="" />Alzheimer Europe’s <a href="https://alzheimereurope.newsweaver.com/Newsletter/1d5hr7hr5qp/external" target="_blank" rel="noopener">June 2021 newsletter</a> brings you the latest news on developments in the dementia field, across Europe and beyond.</p> <p style="text-align: justify;">Summaries of a few of our top stories appear below.</p> <p style="text-align: justify;">Our monthly newsletter reaches around 11,000 people and we are always happy to receive feedback, or suggestions regarding news items to share in future issues.</p> <p style="text-align: justify;"> </p> <p class="centered-only" style="text-align: center;"><a href="https://alzheimereurope.newsweaver.com/Newsletter/1d5hr7hr5qp/external" target="_blank" rel="noopener"><img align="middle" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/28/6534b6316dfaa17784b267.jpg" width="150" height="75" hspace="0" vspace="0" alt="" /></a></p> https://alzheimereurope.newsweaver.com/Newsletter/szz9jxys8x2?lang=en?rss=true On 7 June, the U.S Food and Drug Administration (FDA) approved aducanumab for the treatment of Alzheimer's disease (AD). Biogen's drug is the first AD treatment to be approved by the FDA since 2003, and is the first potentially disease-modifying therapy to reach the market. Biogen is now required to conduct a post-approval clinical trial to verify the anticipated benefit of aducanumab. If this trial does not confirm the drug's benefit for its target population, patients with mild cognitive impairment or mild dementia, the FDA has the possibility of removing the drug from the market. 05 May 2021 12:00:00 CEST 79e72aae0ee9927703ccdafb28e99712 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/eb/ce95a329ac44c0a143986b.jpeg" style="margin: 5px;" width="150" height="79" hspace="5" vspace="5" alt="" />On 7 June, the U.S Food and Drug Administration (FDA) approved aducanumab for the treatment of Alzheimer's disease (AD). Biogen's drug is the first AD treatment to be approved by the FDA since 2003, and is the first potentially disease-modifying therapy to reach the market. Biogen is now required to conduct a post-approval clinical trial to verify the anticipated benefit of aducanumab. If this trial does not confirm the drug's benefit for its target population, patients with mild cognitive impairment or mild dementia, the FDA has the possibility of removing the drug from the market. </p> https://www.alzheimer-europe.org/News/Science-watch/Monday-07-June-2021-FDA-approves-aducanumab-a-first-disease-modifying-treatment-for-Alzheimer-s-disease https://alzheimereurope.newsweaver.com/Newsletter/s5sdbapos3g?lang=en?rss=true Alzheimer Europe’s Annual General Meeting (AGM) was held online, on 14 June. 30 out of 35 full (voting) member organisations were present and during the meeting, following a presentation of our new Strategic Plan 2021-2025 by Executive Director Jean Georges, they voted to adopt the plan. Our strategic objectives for the five-year period 2021-2025 are: Providing a voice to people with dementia and their carers; Making dementia a European priority; Changing perceptions and combatting stigma; Raising awareness of brain health and prevention; Strengthening the European dementia movement; and Supporting dementia research. 03 Jun 2021 12:00:00 CEST efbc9d6a39e3ed04cf29bdf3924e2141 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/c4/fd317ee21520ae8157a232.jpg" style="margin: 5px;" width="150" height="112" hspace="5" vspace="5" alt="" />Alzheimer Europe’s Annual General Meeting (AGM) was held online, on 14 June. 30 out of 35 full (voting) member organisations were present and during the meeting, following a presentation of our new Strategic Plan 2021-2025 by Executive Director Jean Georges, they voted to adopt the plan. Our strategic objectives for the five-year period 2021-2025 are: Providing a voice to people with dementia and their carers; Making dementia a European priority; Changing perceptions and combatting stigma; Raising awareness of brain health and prevention; Strengthening the European dementia movement; and Supporting dementia research.</p> <p style="text-align: justify;"> </p> https://www.alzheimer-europe.org/News/Alzheimer-Europe/Monday-14-June-2021-Alzheimer-Europe-online-Annual-General-Meeting-adopts-new-Strategic-Plan-2021-2025 https://alzheimereurope.newsweaver.com/Newsletter/q5rlatujoss?lang=en?rss=true A new edition of “Dementia in Europe” policy magazine is available, in an electronic format. It highlights our efforts and those of our member associations to make dementia a European priority, and provides updates on the latest national- and European-level policy developments in the dementia field. The magazine is distributed to all Members of the European Parliament (MEPs) and many high-level decision makers in the European Commission. It also reaches lawmakers and politicians in the countries of Alzheimer Europe’s member associations and research professionals from public and private bodies, as well as academic and scientific partners of Alzheimer Europe. We are hugely grateful to all contributors to our magazine and to the sponsors who make its publication possible. 05 May 2021 12:00:00 CEST 40ff55e380aa5bfa1fdbb41bd13cda7e Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/a4/63983bd460b25725376d56.jpg" style="margin: 5px;" width="105" height="150" hspace="5" vspace="5" alt="" />A new edition of “Dementia in Europe” policy magazine is available, in an electronic format. It highlights our efforts and those of our member associations to make dementia a European priority, and provides updates on the latest national- and European-level policy developments in the dementia field. The magazine is distributed to all Members of the European Parliament (MEPs) and many high-level decision makers in the European Commission. It also reaches lawmakers and politicians in the countries of Alzheimer Europe’s member associations and research professionals from public and private bodies, as well as academic and scientific partners of Alzheimer Europe. We are hugely grateful to all contributors to our magazine and to the sponsors who make its publication possible.</p> https://www.alzheimer-europe.org/News/Alzheimer-Europe/Tuesday-15-June-2021-Dementia-in-Europe-issue-36-published-as-an-e-magazine https://alzheimereurope.newsweaver.com/Newsletter/hcl8i0etw4c?lang=en?rss=true On 15 June, Alzheimer Europe hosted an online European Parliament Workshop entitled “The Alzheimer’s spectrum: Changing our understanding of Alzheimer’s disease and dementia”, which was attended by EU policymakers, representatives from national Alzheimer’s associations, national health ministries, pharmaceutical companies, researchers and members of the European Working Group of People with Dementia. MEPs Deirdre Clune (Ireland), Colm Markey (Ireland) and Roberta Metsola (Malta), were present as well as a representative from the office of Włodzimierz Cimoszewicz (Poland). 05 May 2021 12:00:00 CEST 9a228df9f73c6ab0de6ef213997267ca Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/0f/6592b60e41b3f0d312ee16.png" style="margin: 5px;" width="150" height="84" hspace="5" vspace="5" alt="" />On 15 June, Alzheimer Europe hosted an online European Parliament Workshop entitled “The Alzheimer’s spectrum: Changing our understanding of Alzheimer’s disease and dementia”, which was attended by EU policymakers, representatives from national Alzheimer’s associations, national health ministries, pharmaceutical companies, researchers and members of the European Working Group of People with Dementia. MEPs Deirdre Clune (Ireland), Colm Markey (Ireland) and Roberta Metsola (Malta), were present as well as a representative from the office of Włodzimierz Cimoszewicz (Poland). </p> <p style="text-align: justify;"> </p> https://www.alzheimer-europe.org/News/Alzheimer-Europe/Tuesday-15-June-2021-Alzheimer-Europe-hosts-European-Parliament-Workshop-on-The-Alzheimer-s-spectrum-Changing-our-understanding-of-Alzheimer-s-disease-and-dementia https://alzheimereurope.newsweaver.com/Newsletter/qyine7v7got?lang=en?rss=true Alzheimer Europe joins other European health NGOs in asking the European Commission to restore operating grants in the EU4Health Programme to support the vital activities. This call has been issued in response to the publication of the 2021-2022 EU4Health Annual Work Programme by the European Commission. Whilst Alzheimer Europe and other supporting associations welcome the ambitious budget of EUR 312 million for crisis preparedness, disease prevention, health systems and the healthcare workforce and digitalisation, we regret that the operating grant mechanism for European health NGOs has been discontinued by a unilateral decision by the Commission, despite this mechanism having been explicitly included in the EU4Health Programme by the European Parliament and Council of Ministers. 02 Jul 2021 12:00:00 CEST 4205816309fa0c5f6eb954598530b078 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/4b/0a9045c4988a086fbc5b21.jpg" style="margin: 5px;" width="150" height="64" hspace="5" vspace="5" alt="" />Alzheimer Europe joins other European health NGOs in asking the European Commission to restore operating grants in the EU4Health Programme to support the vital activities. This call has been issued in response to the publication of the 2021-2022 EU4Health Annual Work Programme by the European Commission. Whilst Alzheimer Europe and other supporting associations welcome the ambitious budget of EUR 312 million for crisis preparedness, disease prevention, health systems and the healthcare workforce and digitalisation, we regret that the operating grant mechanism for European health NGOs has been discontinued by a unilateral decision by the Commission, despite this mechanism having been explicitly included in the EU4Health Programme by the European Parliament and Council of Ministers.</p> https://www.alzheimer-europe.org/News/Alzheimer-Europe/Friday-25-June-2021-During-greatest-public-health-crisis-in-living-memory-European-Commission-adopts-first-Work-Plan-of-new-EU4Health-Programme-undermining-key-activities-of-European-health-NGOs https://alzheimereurope.newsweaver.com/Newsletter/1p4j9vemqxe?lang=en?rss=true The call for abstracts is now closed for the 31st Alzheimer Europe Conference, taking place online from 29 November to 1 December 2021. We are pleased to have received almost 300 abstracts, all of which will now be reviewed by the Scientific Committee. All submitting authors will be informed of the Committee's decision from 31 July onwards. 02 Jul 2021 12:00:00 CEST 9d3ef1c6b36cf46a135ddb9b3ee6a3da Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/38/67cb1ac074b0cfd01d5365.jpg" style="margin: 5px;" width="150" height="67" hspace="5" vspace="5" alt="" />The call for abstracts is now closed for the 31st Alzheimer Europe Conference, taking place online from 29 November to 1 December 2021. We are pleased to have received almost 300 abstracts, all of which will now be reviewed by the Scientific Committee. All submitting authors will be informed of the Committee's decision from 31 July onwards.</p> https://www.alzheimer-europe.org/News/Alzheimer-Europe/Wednesday-30-June-2021-Alzheimer-Europe-closes-call-for-abstracts-for-31AEC-online-conference